Immunotherapy Biomarkers · Melanoma Clinical Trials
Dr Bach's research focuses on immunotherapy biomarkers — identifying molecular and immunological features that predict which patients will benefit most from checkpoint inhibitor treatment. His published work, produced through international collaborations, has appeared in journals including OncoImmunology, Cancers, The Lancet Regional Health, and Cancer Research (AACR). He is an active clinical investigator in international clinical trials in melanoma at The Clatterbridge Cancer Centre.
Dr Bach is an active clinical investigator in international melanoma trials at The Clatterbridge Cancer Centre — one of the UK's leading cancer research centres. Involvement in clinical research ensures that Dr Bach's practice reflects the most current evidence in melanoma treatment.
During a private consultation, Dr Bach is happy to discuss whether any national or international trials may be relevant to a patient's situation, and can advise on how to access these through appropriate NHS pathways.